FIR Capital Partners, a Brazilian Venture Capital firm, its stake in Prodimol Biotecnologia S.A., a Belo Horizonte, Brazil-based company that manufactures and distributes medical products and pharmaceuticals, to Orgenics, a division of Iverness Medical Innovations of Waltham, Massachusetts.
